Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Pain relief after stroke: spinal cord stimulation plus medicines vs medicines alone

Official title: Efficacy and Safety of Short-Term Spinal Cord Stimulation Combined With Pharmacotherapy for Central Post-Stroke Pain: A Single-Center, Randomized, Controlled Trial

Run by Nanchong Central Hospital · NCT07593313 · Data updated 2026-11-12

This study tests whether adding spinal cord stimulation to standard pain medications helps people with central post-stroke pain see better pain relief than medications alone.

More Central Post Stroke Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorNanchong Central Hospital
Government
Locations1 site (Nanchong, Sichuan)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedAugust 1, 2026
Study endsAugust 1, 2026
Registry record updatedMay 18, 2026
Trial IDNCT07593313 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with chronic CPSP (≥3 months), neuropathic pain features, confirmed stroke, and baseline NRS ≥ 4, who can undergo spinal cord stimulation and comply with follow-up.

Probably not a fit

Patients whose CPSP does not respond to spinal cord stimulation or who have contraindications to SCS or the medications used may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two treatment approaches for central post-stroke pain. Participants receive either spinal cord stimulation combined with gabapentinoids (with optional antidepressants) or gabapentinoids alone (with optional antidepressants). The primary outcome is short-term analgesic effect measured by the Numerical Rating Scale immediately after treatment. Eligible adults have chronic CPSP with neuropathic features and a confirmed stroke, with follow-up planned for at least six months. The study is conducted at Nanchong Central Hospital in Sichuan, under local leadership, with no listed collaborators.

Why it matters

Potential benefit: If successful, participants may experience greater pain reduction and improved daily function from the combined therapy.

How similar studies have gone: Previous work suggests potential benefit of combining neuromodulation with pharmacotherapy for CPSP, but results vary by setting and patient characteristics.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of central post-stroke pain (CPSP) according to the International Association for the Study of Pain (IASP) criteria
* Clear history of stroke confirmed by cranial CT or MRI
* Pain occurring after stroke and distributed in body parts corresponding to central nervous system injury
* Pain with neuropathic characteristics (e.g., burning sensation, electric shock sensation, needle prick sensation)
* Pain not explained by other causes
* Age ≥ 18 years
* Pain duration ≥ 3 months
* Baseline pain Numerical Rating Scale (NRS) score ≥ 4 points
* Complete clinical data with follow-up time ≥ 6 months

Exclusion Criteria:

* History of chronic pain before stroke
* Severe cognitive impairment that prevents cooperation with pain assessment (Mini-Mental State Examination, MMSE \< 15 points)
* Contraindications to spinal cord stimulation (SCS), such as coagulation disorders, active infections, or mental diseases that prevent cooperation
* Malignant tumors or other severe organic diseases with expected survival \< 1 year

Where it's running

  • Nanchong Central Hospital
    Nanchong, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.